Next-generation sequencing is widely regarded as a transformative technology that delivers potentially life-prolonging therapies to patients with advanced cancers. Yet the testing is still underused ...

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

In this analysis, researchers explored patterns of surgical care and factors associated with undergoing bilateral mastectomy as primary breast surgery.

Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...

On-site automated NGS using circulating tumor DNA enabled comprehensive genomic testing in ~27 hours, substantially shortening the interval between diagnosis and potential targeted-therapy selection.

Genetic testing is usually performed on blood or saliva to look for inherited changes or genetic predisposition. Genomic ...

Lucknow: Cancer patients in Uttar Pradesh and neighbouring states can now access genomic testing locally with the launch of ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

A WISDOM Study analysis shows that pathogenic variant testing can uncover high-risk women who may not qualify for earlier or more intensive breast screening under standard clinical and polygenic risk ...

A prospective Canadian study suggests that moving beyond narrow, cancer-specific molecular panels toward broader genomic ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. After a cancer diagnosis, patients often have many ...

Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and researchers, reducing the ...